A clinical decision model for failed adrenal vein sampling in primary aldosteronism
- PMID: 39897961
- PMCID: PMC11782024
- DOI: 10.3389/fendo.2024.1497787
A clinical decision model for failed adrenal vein sampling in primary aldosteronism
Abstract
Objective: Primary aldosteronism (PA) is a common cause of secondary hypertension with unilateral and bilateral subtypes requiring different treatments. Adrenal vein sampling (AVS) is the gold standard for subtype differentiation but can be unsuccessful by challenging right adrenal vein anatomy. This study aimed to develop a clinical decision model using only measurements from the left adrenal vein (LAV) and peripheral blood (IVC) to differentiate between PA subtypes.
Methods: The retrospective cohort study included 54 PA patients who underwent bilaterally successful AVS. The main objective was to determine optimal cut-off values for the LAV/IVC index, using ROC analysis for subtype prediction. The predictive value of this index was assessed with the Area Under the Curve (AUC). The Youden index calculated cut-off values, targeting a specificity >90% for PA subtype differentiation.
Results: The cohort, averaging 48.5 ± 9.5 years in age, comprised 21 women and 33 men, among whom 26 presented with unilateral and 28 with bilateral disease. LAV/IVC values <1.2 indicated unilateral right-sided disease (specificity 91%, sensitivity 96%, AUC 0.98, 95% confidence interval (CI) 0.95-1.0), values 1.2-2.4 suggested bilateral disease (sensitivity 93%, specificity 64%, AUC 0.85, CI 0.73-0.96), whereas values ≥4.4 predicted unilateral left-sided disease (specificity 93%, sensitivity 60%, AUC 0.85, CI 0.73-0.96). Published literature aligns with our results on cut-off values.
Conclusions: Utilizing the LAV/IVC index, over 70% of unsuccessful AVS procedures due to failed right adrenal cannulation could be interpreted with over 90% certainty regarding the PA subtype, preventing unnecessary resampling and aiding in determining the preferred treatment.
Keywords: LAV/IVC index; adrenal vein sampling; adrenalectomy; disease subtype; failed right cannulation; primary aldosteronism.
Copyright © 2025 ter Haar, van Goor, Corssmit, van Erkel, Ballieux, Dekkers and Nijhoff.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Can incomplete adrenal venous sampling data be used in predicting the subtype of primary aldosteronism?Ann Endocrinol (Paris). 2019 Nov;80(5-6):301-307. doi: 10.1016/j.ando.2019.10.001. Epub 2019 Oct 18. Ann Endocrinol (Paris). 2019. PMID: 31722788
-
A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.World J Surg. 2018 Feb;42(2):466-472. doi: 10.1007/s00268-017-4327-6. World J Surg. 2018. PMID: 29124355
-
Primary aldosteronism: making sense of partial data sets from failed adrenal venous sampling-suppression of adrenal aldosterone production can be used in clinical decision making.Surgery. 2018 Apr;163(4):801-806. doi: 10.1016/j.surg.2017.10.012. Epub 2017 Nov 22. Surgery. 2018. PMID: 29174432
-
Tools to Predict Unilateral Primary Aldosteronism and Optimise Patient Selection for Adrenal Vein Sampling: A Systematic Review.Clin Endocrinol (Oxf). 2025 Jul;103(1):3-12. doi: 10.1111/cen.15225. Epub 2025 Mar 18. Clin Endocrinol (Oxf). 2025. PMID: 40099563 Free PMC article.
-
Wide Variability in Catecholamine Levels From Adrenal Venous Sampling in Primary Aldosteronism.J Surg Res. 2022 Sep;277:1-6. doi: 10.1016/j.jss.2022.03.016. Epub 2022 Apr 19. J Surg Res. 2022. PMID: 35453052 Review.
References
-
- Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. . Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. (2017) 5:689–99. doi: 10.1016/S2213-8587(17)30135-3 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources